Development and validation of bioanalytical method for the determination of asulacrine in plasma by liquid chromatography

Journal of Pharmaceutical and Biomedical Analysis

Volumn 46, Issue 2, 2008, Pages 386-390

  Ganta, Srinivas ^a   Paxton, James W ^b   Baguley, Bruce C ^c   Garg, Sanjay ^a  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Amsacrine; Asulacrine; Pharmacokinetics; UV detection

Indexed keywords

ACETIC ACID; ACETONITRILE; ANILIDE; ANTINEOPLASTIC AGENT; ASULACRINE; ASULACRINE ISETHIONATE; BUFFER; SN 21407; SULFONE DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG METABOLISM; DRUG STABILITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; VALIDATION PROCESS;

AMSACRINE; ANIMALS; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, LIQUID; MICE; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 37749043972     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.09.025     Document Type: Article

References (12)

1. Cain B.F., Atwell G.J., and Denny W.A. J. Med. Chem. 18 (1975) 1110-1117
2. Baguley B.C., Denny W.A., Atwell G.J., Finlay G.J., Rewcastle G.W., Twigden S.J., and Wilson W.R. Cancer Res. 44 (1984) 3245-3251
3. Schneider E., Darkin S.J., Lawson P.A., Ching L.M., Ralph R.K., and Baguley B.C. Eur. J. Cancer Clin. Oncol. 24 (1988) 1783-1790
4. Covey J.M., Kohn K.W., Kerrigan D., Tilchen E.J., and Pommier Y. Cancer Res. 48 (1988) 860-865
5. Baguley B.C. Biophys. Chem. 35 (1990) 203-212
6. Sklarin N.T., Wiernik P.H., Grove W.R., Benson L., Mittelman A., Maroun J.A., Stewart J.A., Robert F., Doroshow J.H., Rosen P.J., Jolivet J., Ruckdeschel J.C., Robert N.J., Vèlez-Garcìa E., Bergsagel D.E., Panasci L.C., Merwe A.M., Longueville J.J., Leiby J., and Kowal C.D. Invest. New Drugs 10 (1992) 309-312
7. Jurlina J.L., and Paxton J.W. J. Chromatogr. B: Biomed. Sci. Appl. 342 (1985) 431-435
8. Jurlina J.L., and Paxton J.W. J. Chromatogr. B: Biomed. Sci. Appl. 276 (1983) 367-374
9. Chen C.L., Thoen K.K., and Uckun F.M. J. Chromatogr. B: Biomed. Sci. Appl. 764 (2001) 81-119
10. Kestell P., Paxton J.W., Evans P.C., Young D., Jurlina J.L., Robertson I.G.C., and Baguley B.C. Cancer Res. 50 (1990) 503-508
11. FDA-CDER and CVM Guidance for industry, Bioanalytical method validation (2001).
12. Shah V.P., Midha K.K., Findlay J.W., Hill H.M., Hulse J.D., McGilveray I.J., McKay G., Miller K.J., Patnaik R.N., Powell M.L., Tonelli A., Viswanathan C.T., and Yacobi A. Pharm. Res. 17 (2000) 1551-1557